wilcoxDr. Wilcox has been serving as  Professor of Medicine and the Division Director since joining UAB in 2001.  During this time, Dr. Wilcox has guided the Division into becoming one of the leaders in the treatment of gastrointestinal and digestive disorders in the region.  He is a leading expert in the treatment of Zollinger-Ellison syndrome and disorders relating to pancreatiobiliary disease.  Dr. Wilcox serves on several editorial boards of scholarly journals including Clinical Gastroenterology and Hepatology (editor) and American Journal of Medicine (associate editor) among others.  He is active in instruction with fellowship program as well as providing lectures and presentations on the treatment and procedures available for gastrointestinal disorders.  Dr. Wilcox received his medical degree from the Medical College of Georgia. He completed his internship and residency at UAB and fellowship training in gastroenterology at UCSF. His current research interests include includes the role of endoscopic therapy in the treatment of pancreaticobiliary diseases.

Physician Provider Profile

Recent Publications

  1. Progress in the management of necrotizing pancreatitis.
    Wilcox CM, Varadarajulu S, Morgan D, Christein J.
    Expert Rev Gastroenterol Hepatol. 2010 Dec;4(6):701-8
  2. Treatment strategies for Zollinger-Ellison syndrome.
    Wilcox CM, Hirschowitz BI. Expert Opin Pharmacother. 2009 May;10(7):1145-57.
  3. CGH receives high impact factor.
    Wilcox CM. Clin Gastroenterol Hepatol. 2009 Jan;7(1):6. Epub 2008 Nov 24
  4. Should patients undergoing ERCP be placed in the prone or supine position?
    Wilcox CM. Nat Clin Pract Gastroenterol Hepatol. 2008 Sep;5(9):488-9.
  5. Absence of gastrointestinal infections in a cohort of patients with Zollinger-Ellison syndrome and
    other acid hypersecretors receiving long-term acid suppression with lansoprazole.

    Wilcox CM, Martin T, Phadnis M, Mohnen J, Worthington J, Hirschowitz BI. BMC Gastroenterol. 2008 May 28;8:18
  6. Exploring the use of the sham design for interventional trials: implications for endoscopic research.
    Wilcox CM. Gastrointest Endosc. 2008 Jan;67(1):123-7.